Classifications of heart muscle diseases have proved to be exceedingly complex and in
many respects contradictory. Indeed, the precise language used to describe these diseases …

Background—In 1994, an International Task Force proposed criteria for the clinical
diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that …

Since its introduction as a clinical entity in 1992, the Brugada syndrome has progressed
from being a rare disease to one that is second only to automobile accidents as a cause of …

4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

ContextA nationwide systematic preparticipation athletic screening was introduced in Italy in
1982. The impact of such a program on prevention of sudden cardiovascular death in the …

From 1979 to 1986, we conducted postmortem studies of 60 persons under 35 years of age
who had died suddenly in the Veneto Region of northeastern Italy. Unexpectedly, we found …

Objectives: We sought to assess the risk of sudden death (SD) in both male and female
athletes age 12 to 35 years. Background: Little is known about the risk of SD in adolescents …

The 1996 American Heart Association consensus panel recommendations stated that pre-
participation cardiovascular screening for young competitive athletes is justifiable and …

in a superior intercostal space in individuals with high clinical suspicion (aborted sudden
cardiac death victims, family members of patients with Brugada syndrome) may also …